DugbateyK. (1999) ‘National Health policies: Sub-Saharan African case studies (1980–1990)’, Social Science & Medicine, 49(2), 223–240. Available at: www.sciencedirect.com.ezp1.
2.
WendoC. (2001) ‘Uganda's drug regulatory agency faces financial crisis’, The Lancet, 358(9280), 482.
3.
MDG (2005) ‘Country case study: Access to medicines in Uganda: Intersections with poverty’, Millennium Development Goals Report on Essential Medicines, Appendix 1.
UNDP (2004) ‘Mixed Fortunes (1997–2003)’, Thailand's Response to HIV/AIDS: Progress and Challenges, Ch.6. Available at: www.undp.or.th/HIVReport.htm.
12.
PannarunothaiS. (2004) ‘Universal health coverage in Thailand: Ideas for reform and policy struggling’, Health Policy68, 17–30.
13.
TeerawattananonY. (2003) ‘Health sector regulation in Thailand: Recent progress and the future agenda’, Health Policy63, 3233–338.
14.
TangcharoensathienV. (2004) ‘Knowledge-based changes to health systems: The Thai experience in policy development’, Bulletin of the World Health Organization, 82(10), 750.
15.
Health GAP (Global Access Project) (2003) ‘Thai network of people living with HIV/AIDS’, (TNP+) Press Statement. Available at: www.healthgap.org.
16.
KazminA. (2004) ‘Dose of optimism in fighting AIDS, Bristol-Myers drops a patent battle, allowing Thais to make the drug didanosine more affordable – and perhaps sets a precedent’, Financial Times, 1 March.
17.
WilsonD. (1999) ‘Global trade and access to medicines: AIDS treatments in Thailand’, The Lancet354, 1893–1895.
18.
FordN. (2004) ‘The role of civil society in protecting public health over commercial interests: Lessons from Thailand’, The Lancet, 363, 14 February.
